MOB3C: A Potential Drug Target for Cellular Processes (G148932)

Target Name: MOB3C

NCBI ID: G148932

MOB3C

MOB3C: A Potential Drug Target for Cellular Processes

MOB3C, also known as mob1 homolog 2C (MOB3C), is a protein that is expressed in various tissues throughout the body. It is a key regulator of cell growth and differentiation, and is involved in the development and maintenance of tissues such as blood vessels , neural tubes, and epithelial cells. MOB3C has also been shown to play a role in the regulation of cellular processes such as cell cycle progression, apoptosis, and angiogenesis.

One of the key functions of MOB3C is its role in the regulation of cell cycle progression. MOB3C is a critical regulator of the G1/S transition, which is the stage at which a cell prepares for cell division. During the G1/S transition, MOB3C helps to ensure that the cell has enough copies of its chromosomes to divide correctly. MOB3C also plays a role in the regulation of the G2/M transition, which is the stage at which the cell prepares for cell division. During this transition, MOB3C helps to ensure that the cell has the necessary RNA and protein resources for cell division.

Another important function of MOB3C is its role in the regulation of apoptosis. Apoptosis is a natural process that helps to remove damaged or dysfunctional cells from the body. MOB3C is involved in the regulation of apoptosis by helping to ensure that the cell has the necessary signaling molecules to undergo apoptosis. MOB3C has also been shown to play a role in the regulation of cellular stress, which can help to contribute to the development of diseases such as cancer.

MOB3C is also involved in the regulation of angiogenesis, which is the process by which new blood vessels are formed in the body. MOB3C plays a role in the regulation of angiogenesis by helping to ensure that the cell has the necessary signaling molecules to form new blood vessels. This is important because many diseases, such as heart disease and diabetes, are caused by problems with the development and function of blood vessels.

In addition to its role in the regulation of cell cycle progression, apoptosis, and angiogenesis, MOB3C has also been shown to play a role in the regulation of cellular processes such as cell signaling and inflammation. MOB3C is involved in the regulation of cellular signaling by helping to ensure that the cell has the necessary signaling molecules to communicate with other cells. It is also involved in the regulation of inflammation by helping to control the signaling pathways that contribute to the development of diseases such as cancer.

Given the many important functions of MOB3C, it is not surprising that it has been identified as a potential drug target. Many studies have shown that MOB3C plays a role in the development and progression of a wide range of diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. MOB3C is also a good candidate for targeting because it is expressed in a wide range of tissues and cells, making it a potential target for small molecule inhibitors.

In conclusion, MOB3C is a protein that is involved in the regulation of cell growth and differentiation, the development and maintenance of tissues, and the regulation of cellular processes such as cell cycle progression, apoptosis, and angiogenesis. It is a potential drug target due to its involvement in the development and progression of a wide range of diseases. Further research is needed to fully understand the role of MOB3C in these processes and to develop effective small molecule inhibitors.

Protein Name: MOB Kinase Activator 3C

Functions: May regulate the activity of kinases

The "MOB3C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MOB3C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets